FORNARO, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 293
EU - Europa 287
AS - Asia 109
SA - Sud America 4
Totale 693
Nazione #
US - Stati Uniti d'America 280
IT - Italia 110
IE - Irlanda 90
CN - Cina 48
GB - Regno Unito 23
SG - Singapore 21
UA - Ucraina 14
CA - Canada 13
DE - Germania 13
SE - Svezia 11
FI - Finlandia 8
HK - Hong Kong 8
IN - India 7
TR - Turchia 7
VN - Vietnam 7
CZ - Repubblica Ceca 5
ES - Italia 4
KR - Corea 4
BR - Brasile 3
AZ - Azerbaigian 2
IR - Iran 2
NL - Olanda 2
AT - Austria 1
BE - Belgio 1
DK - Danimarca 1
FR - Francia 1
IL - Israele 1
JP - Giappone 1
LV - Lettonia 1
MY - Malesia 1
PE - Perù 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 693
Città #
Dublin 90
Chandler 54
Ashburn 47
Milan 38
Singapore 20
Redmond 17
New York 14
Ann Arbor 13
Beijing 13
Southend 12
Toronto 12
Jacksonville 11
Los Angeles 9
Boston 8
Helsinki 8
Hong Kong 8
Dong Ket 7
Lawrence 6
Modena 6
Palombara Sabina 6
Tolentino 5
Boardman 4
Brno 4
Busto Arsizio 4
Mountain View 4
Munich 4
Piobesi Torinese 4
Rome 4
Seoul 4
Vic 4
Piacenza 3
Redwood City 3
São Paulo 3
Wilmington 3
Baku 2
Chennai 2
Des Moines 2
Duncan 2
Fairfield 2
Imola 2
London 2
New Delhi 2
Pune 2
Segrate 2
Aarhus 1
Amsterdam 1
Atlanta 1
Bologna 1
Bonndorf 1
Brussels 1
Cesa 1
Chenzhou 1
Chieri 1
Clifton 1
Cormano 1
Edison 1
Frankfurt am Main 1
Fremont 1
Lazzate 1
Lima 1
Linyi 1
Mascalucia 1
Montescaglioso 1
Montù Beccaria 1
Napoli 1
Nardò 1
Nashville 1
Norwalk 1
Omaha 1
Ottawa 1
Padova 1
Prague 1
Riga 1
San Diego 1
Seattle 1
Shangqiu 1
St Petersburg 1
Stockholm 1
Tappahannock 1
Tel Aviv 1
Tokyo 1
Warsaw 1
Weihai 1
Woodbridge 1
Xiamen 1
Yuncheng 1
Zanjan 1
Totale 515
Nome #
Do social values and institutional context shape the use of economic evaluation in reimbursement decisions? An empirical analysis 134
Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the Italian National Health Service 133
Broadening the concept of value: a scoping review on the option value of medical technologies 93
Cost-effectiveness and net monetary benefit of Olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed advanced BRCA1/2-mutated ovarian cancer in the Italian National Health Service 90
Value-based healthcare: il nuovo approccio di AIFA alla determinazione multidimensionale del valore 81
Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome 75
The impact of surgical experience in VATS lobectomy on conversion and patient quality of life: results from a comprehensive national video-assisted thoracic surgical database 45
The value of hearing aids for the Italian NHS: a cost-utility analysis 40
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy? 29
Assessing the long-term prognostic ability of the 70 gene expression signature MammaPrint in an Italian single-center prospective cohort study of early-stage intermediate-risk breast cancer patients 6
Totale 726
Categoria #
all - tutte 4.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.393


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 0 0 0 0 0 0 12 1 3 7 10 10
2020/202196 3 5 2 3 5 7 8 7 9 3 6 38
2021/202293 6 14 2 1 5 0 2 14 5 11 16 17
2022/2023239 13 15 8 17 5 17 9 12 109 5 17 12
2023/2024187 7 4 10 3 16 26 18 50 5 10 20 18
2024/202568 11 3 15 6 26 7 0 0 0 0 0 0
Totale 726